Trial intelligence / Profile preview

Nicardipine Dose Adjustment in Hypertensive Emergency

NCT01872039Phase 4Completed

Sponsor
Astellas Pharma
Start
Mar 2013
Primary completion
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nicardipine in hypertensive emergency, sponsored by Astellas Pharma. Started Mar 2013; status: completed.

02

Drugs

nicardipine
03

Conditions

hypertensive emergency

Beyond the preview

Go deeper on NCT01872039.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01872039.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call